Invention Grant
- Patent Title: Compounds 679
- Patent Title (中): 化合物679
-
Application No.: US12052908Application Date: 2008-03-21
-
Publication No.: US07964616B2Publication Date: 2011-06-21
- Inventor: Mark Ebden , Simon David Guile
- Applicant: Mark Ebden , Simon David Guile
- Applicant Address: SE Sodertalje
- Assignee: AstraZeneca AB
- Current Assignee: AstraZeneca AB
- Current Assignee Address: SE Sodertalje
- Agency: Fish & Richardson P.C.
- Main IPC: A61K31/04
- IPC: A61K31/04 ; C07D215/38
Abstract:
The invention provides compounds of formula (I), processes for their preparation, pharmaceutical compositions containing them, a process for preparing the pharmaceutical compositions, and their use in therapy, wherein R1, R2, R3 and n are as defined in the specification
Public/Granted literature
- US20080234319A1 Novel Compounds 679 Public/Granted day:2008-09-25
Information query
